ReviewF1000Research2017
Recent advances in managing septal defects: atrial septal defects.
Review in F1000Research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 52 citations in OpenAlex.
- Efficacy and Safety of Transarterial Retrograde Approach in Ventricular Septal Defect Closure: A Systematic Review and Meta-Analysis.Anatolian journal of cardiology · 2025Pooled it
- Comparison of Figulla Flex® and Amplatzer™ devices for atrial septal defect closure: A meta-analysis.Cardiology journal · 2020Pooled it
- Efficacy and safety of transseptal puncture-assisted atrial fibrillation ablation in patients with atrial septal occluder devices: an updated systematic review and meta-analysis.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2026Review
- The safety and effectiveness of a modified guidewire pigtailing technique in transesophageal echocardiography-guided percutaneous closure of secundum atrial septal defects.BMC cardiovascular disorders · 2026Article
- Atrial Septal Defects: From Embryology to Pediatric Pulmonary Hypertension.Journal of clinical medicine · 2025Review
- Can Artificial Intelligence Revolutionize the Diagnosis and Management of the Atrial Septal Defect in Children?Diagnostics (Basel, Switzerland) · 2024Review
- Prevalence of Echocardiographic Profile and Its Related Risk Factors in Congenital Heart Disease Patients; A Cross-Sectional Study.Galen medical journal · 2024Article
- Case report: A unique quadruple coexisting anomaly-scimitar syndrome, atrial septal defect, vascular ring, and pulmonary sequestration.Frontiers in pediatrics · 2023Article
- Transcatheter Atrial Septal Defect Closure Before Versus After Adulthood.Journal of the Saudi Heart Association · 2022Article
- Association between the Use of Diuretics and Size Reduction in Pediatric Atrial Septal Defect.Korean circulation journal · 2021Article
- Cost comparison of transcatheter and operative closures for patients with secundum atrial septal defects in Vietnam.Heliyon · 2021Article
- Key Regulatory Differentially Expressed Genes in the Blood of Atrial Septal Defect Children Treated With Occlusion Devices.Frontiers in genetics · 2021Article
- Cardiopulmonary haemodynamics after sieve-shaped atrial septal defect repair: a multicenter study.American journal of translational research · 2021Article
- Wide unroofed coronary sinus and cryptogenic stroke: a case report.European heart journal. Case reports · 2020Article
- Revising ventricular septal defect residual shunts without aortic re-cross-clamping: a safe and effective surgical procedure.Annals of translational medicine · 2020Article
- Outcomes of Device Closure of Atrial Septal Defects.Children (Basel, Switzerland) · 2020Review
- Autopsy in adults with congenital heart disease (ACHD).Virchows Archiv : an international journal of pathology · 2020Review
- Normalization of the right heart and the preoperative factors that influence the emergence PAH after surgical closure of atrial septal defect.Journal of cardiothoracic surgery · 2020Article
- Trends in the Prevalence of Atrial Septal Defect and Its Associated Factors among Congenital Heart Disease Patients in Vietnam.Journal of cardiovascular development and disease · 2019Article
- Management of Congenital Heart Disease: State of the Art; Part I-ACYANOTIC Heart Defects.Children (Basel, Switzerland) · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The purpose of this review is to discuss the management of atrial septal defects (ASD), paying particular attention to the most recent developments. There are four types of ASDs: ostium secundum, ostium primum, sinus venosus, and coronary sinus defects. The fifth type, patent foramen ovale-which is present in 25 to 30% of normal individuals and considered a normal variant, although it may be the seat of paradoxical embolism, particularly in adults-is not addressed in this review. The indication for closure of the ASDs, by and large, is the presence of right ventricular volume overload. In asymptomatic patients, the closure is usually performed at four to five years of age. While there was some earlier controversy regarding ASD closure in adult patients, currently it is recommended that the ASD be closed at the time of presentation. Each of the four defects is briefly described followed by presentation of management, whether by surgical or percutaneous approach, as the case may be. Of the four types of ASDs, only the ostium secundum defect is amenable to percutaneous occlusion. For ostium secundum defects, transcatheter closure has been shown to be as effective as surgical closure but with the added benefits of decreased hospital stay, avoidance of a sternotomy, lower cost, and more rapid recovery. There are several FDA-approved devices in use today for percutaneous closure, including the Amplatzer® Septal Occluder (ASO), Amplatzer® Cribriform device, and Gore HELEX® device. The ASO is most commonly used for ostium secundum ASDs, the Gore HELEX® is useful for small to medium-sized defects, and the cribriform device is utilized for fenestrated ASDs. The remaining types of ASDs usually require surgical correction. All of the available treatment modes are safe and effective and prevent the development of further cardiac complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.